Most just lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent regions as classical opioid receptors, it binds to some wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts being a scavenger and does not activat